| The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer RM Bremnes, LT Busund, TL Kilvær, S Andersen, E Richardsen, ... Journal of Thoracic Oncology 11 (6), 789-800, 2016 | 468 | 2016 |
| Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer T Donnem, SM Hald, EE Paulsen, E Richardsen, S Al-Saad, TK Kilvaer, ... Clinical Cancer Research 21 (11), 2635-2643, 2015 | 311 | 2015 |
| Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer T Donnem, TK Kilvaer, S Andersen, E Richardsen, EE Paulsen, SM Hald, ... Annals of oncology 27 (2), 225-232, 2016 | 185 | 2016 |
| Prognostic value of macrophage phenotypes in resectable non–small cell lung cancer assessed by multiplex immunohistochemistry M Rakaee, LTR Busund, S Jamaly, EE Paulsen, E Richardsen, ... Neoplasia 21 (3), 282-293, 2019 | 131 | 2019 |
| Prognostic impact of lymphocytes in soft tissue sarcomas SW Sorbye, T Kilvaer, A Valkov, T Donnem, E Smeland, K Al-Shibli, ... PLoS One 6 (1), e14611, 2011 | 117 | 2011 |
| Assessing PDL-1 and PD-1 in non–small cell lung cancer: a novel immunoscore approach EE Paulsen, TK Kilvaer, MR Khanehkenari, S Al-Saad, SM Hald, ... Clinical lung cancer 18 (2), 220-233. e8, 2017 | 92 | 2017 |
| CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases EE Paulsen, TK Kilvaer, M Rakaee, E Richardsen, SM Hald, S Andersen, ... Cancer Immunology, Immunotherapy 66, 1449-1461, 2017 | 90 | 2017 |
| Cancer associated fibroblasts in stage I-IIIA NSCLC: prognostic impact and their correlations with tumor molecular markers TK Kilvaer, MR Khanehkenari, T Hellevik, S Al-Saad, EE Paulsen, ... PloS one 10 (8), e0134965, 2015 | 80 | 2015 |
| CD45RO+ Memory T Lymphocytes—a candidate marker for TNM-immunoscore in squamous non–small cell lung cancer EE Paulsen, T Kilvaer, MR Khanehkenari, RJ Maurseth, S Al-Saad, ... Neoplasia 17 (11), 839-848, 2015 | 71 | 2015 |
| Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas SW Sorbye, TK Kilvaer, A Valkov, T Donnem, E Smeland, K Al-Shibli, ... Public Library of Science 7 (10), e47068, 2012 | 67 | 2012 |
| Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer M Rakaee, LT Busund, EE Paulsen, E Richardsen, S Al-Saad, ... Oncotarget 7 (44), 72184, 2016 | 66 | 2016 |
| Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non–small cell lung cancer M Rakaee, TK Kilvaer, SM Dalen, E Richardsen, EE Paulsen, SM Hald, ... Human pathology 79, 188-198, 2018 | 63 | 2018 |
| LAG-3 in non–small-cell lung cancer: expression in primary tumors and metastatic lymph nodes is associated with improved survival SM Hald, M Rakaee, I Martinez, E Richardsen, S Al-Saad, EE Paulsen, ... Clinical lung cancer 19 (3), 249-259. e2, 2018 | 63 | 2018 |
| Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer K Skjefstad, T Grindstad, MR Khanehkenari, E Richardsen, T Donnem, ... Steroids 113, 5-13, 2016 | 58 | 2016 |
| Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer M Rakaee, TK Kilvaer, S Jamaly, T Berg, EE Paulsen, M Berglund, ... British Journal of Cancer 124 (10), 1680-1689, 2021 | 56 | 2021 |
| Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis TK Kilvaer, A Valkov, S Sorbye, E Smeland, RM Bremnes, LT Busund, ... PloS one 5 (12), e15368, 2010 | 47 | 2010 |
| Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer TK Kilvaer, M Rakaee, T Hellevik, A Østman, C Strell, RM Bremnes, ... PLoS One 13 (2), e0192157, 2018 | 46 | 2018 |
| Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas SW Sorbye, TK Kilvaer, A Valkov, T Donnem, E Smeland, K Al-Shibli, ... BMC clinical pathology 12, 1-10, 2012 | 46 | 2012 |
| Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival SM Hald, Y Kiselev, S Al-Saad, E Richardsen, C Johannessen, ... BMC cancer 15, 1-11, 2015 | 45 | 2015 |
| The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas A Valkov, SW Sorbye, TK Kilvaer, T Donnem, E Smeland, RM Bremnes, ... PLoS One 6 (3), e17507, 2011 | 42 | 2011 |
Mehrdad RakaeeHarvard Medical School在 bwh.harvard.edu 的电子邮件经过验证
